New obesity indices and adipokines in normotensive patients and patients with hypertension: Comparative pilot analysis

Angiology

Volumn 65, Issue 4, 2014, Pages 333-342

  Stȩpień, Mariusz ^a   Stȩpień, Anna ^a   Banach, Maciej ^a   Wlazeł, Rafał N ^a   Paradowski, Marek ^a   Rizzo, Manfredi ^b,c   Toth, Peter P ^d,e   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF PALERMO   (Italy)

^c Euro Mediterranean Institute of Science and Technology   (Italy)

^d CGH Medical Center   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

Author keywords

adipokines; hypertension; obesity; obesity indices

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; RESISTIN;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HIP CIRCUMFERENCE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OUTPATIENT; PILOT STUDY; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; WEIGHT HEIGHT RATIO;

ADIPOKINES; HYPERTENSION; OBESITY; OBESITY INDICES;

ADIPONECTIN; ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; OBESITY; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; RESISTIN; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84892556262     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713485807     Document Type: Article

References (41)

1. Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. Mechanisms of obesity-induced hypertension. Hypertens Res. 2010 ; 33 (5). 386-393
2. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology and clinical management. Am J Hypertens. 2010 ; 23 (11). 1170-1178
3. Galletti F, D'Elia L, Barba G, et al. High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: results of an eight-year follow-up study. J Clin Endocrinol Metab. 2008 ; 93 (10). 3922-3926
4. Asferg C, Møelvang R, Flyvbjerg A, et al. Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. Am J Hypertens. 2010 ; 23 (3). 327-333
5. Coreia ML, Haynes WG. Obesity-related hypertension: is there a role for selective leptin resistance?. Curr Hypertens Rep. 2004 ; 6 (3). 230-235
6. Mark AL, Agassandian K, Morgan DA, Liu X, Cassell MD, Rahmouni K. Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension. 2009 ; 53 (2). 375-380
7. Stȩpień M, Wlazeł RN, Paradowski M, et al. Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study. Arch Med Sci. 2012 ; 8 (3). 431-436
8. Yiannikouris F, Gupte M, Putnam K, Cassis L. Adipokines and blood pressure control. Curr Opin Nephrol Hypertens. 2010 ; 19 (2). 195-200
9. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007 ; 28 (7). 850-856
10. Ashwell M, Gibson S. Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British national diet and nutrition survey of adults aged 19-64 years. Obesity facts. Eur J Obes. 2009 ; 2 (2). 97-103
11. Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008 ; 61 (7). 646-653
12. Amato MC, Giordano C, Galia M, et al. Visceral adiposity index. A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010 ; 33 (4). 920-922
13. Stȩpień A, Stȩpień M, Wlazeł R, et al. New indices of visceral adiposity and its correlation with hs-CRP in patients with obesity. Clin Exp Med Lett. 2011 ; 52 (3-4). 91-95
14. Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity. 2011 ; 19 (5). 1083-1089
15. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003 ; 88 (10). 4848-4856
16. Ashwell M.. Charts based on body mass index and waist-to-height ratio to assess the health risk of obesity: a review. Open Obes J. 2011 ; 3: 78-84
17. Li WC, Chen IC, Chang YC, Loke SS, Wang SH, Hsiao KY. Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults. Eur J Nutr. 2013 ; 52 (1). 57-65
18. Hu YH, Reilly KH, Liang YJ, et al. Increase in body mass index, waist circumference and waist-to-height ratio is associated with high blood pressure in children and adolescents in China. J Int Med Res. 2011 ; 39 (1). 23-32
19. Chen TL, Choy CS, Chan WY, Chen CH, Liao CC. Waist-to-height ratio and elevated blood pressure among children in Taiwan. Indian Pediatr. 2012 ; 49 (6). 463-465
20. Assal HB, Fath-allah M, Elsherbiny A. Serum leptin and adiponectin in obese diabetic and non-diabetic. J Med Sci. 2007 ; 7 (5). 865-869
21. Lee HS, Lee M, Joung H. Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. Asia Pac J Clin Nutr. 2007 ; 16 (10). 10-15
22. Stepien M, Rosniak-Bak K, Paradowski M, et al. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med Sci Monit. 2011 ; 17 (11). PR13 - PR18
23. Park KG, Park KS, Kim MJ, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diab Res Clin Pract. 2004 ; 63 (2). 135-142
24. Corica F, Allegra A, Corsonello A, et al. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Int J Obes Rel Metab Disord. 1999 ; 23 (4). 355-360
25. Luizzi A, Savia G, Tagliaferri M, et al. Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord. 1999 ; 23 (10). 1066-1073
26. Coello SD, de Leon AC, González DA, et al. Inverse association between serum resistin and insulin resistance in humans. Diab Res Clin Pract. 2008 ; 82 (2). 256-261
27. Melmer A, Lamina C, Tschoner A, et al. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors [Published online on June 22, 2012]. Obesity (Silver Spring). 2012 ;:
28. Silva M, Vale B, Lemoc C, Torres M, Bregman R. Body adiposity index assess body fat with high accuracy in nondialyzed chronic kidney disease patients [Published online on June 22, 2012]. Obesity (Silver Spring). 2012 ;:
29. Stepien M, Stepien A, Wlazel RN, et al. Predictors of insulin resistance in patients with obesity: a pilot study. Angiology. 2014 ; 65 (1). 22-30
30. Minocci A, Savia G, Lucantoni R, et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes. 2000 ; 24 (9). 1139-1144
31. El Kholy O, Eid F, Al RA, Gorgi M. Relationship between adipocytokines (leptin, adiponectin) and arterial blood pressure. Biochim Clin. 2006 ; 30 (3). 185-189
32. Hall JE, da Silva A, do Carmo JM, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin and melanocortins. J Biol Chem. 2010 ; 285 (23). 1771-1776
33. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010 ; 11 (1). 11-18
34. Ferrannini E, Sironi AM, Iozzo P, et al. Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk. Eur Heart J Suppl. 2008 ; 10 (suppl B). B4 - B10
35. Deng WW, Wang J, Liu MM, et al. Body mass index compared with abdominal obesity indicators in relation to prehypertension and hypertension in adults: the CHPSNE study. Am J Hypertens. 2013 ; 26 (1). 58-67
36. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003 ; 46 (4). 459-469
37. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002 ; 147 (2). 173-180
38. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002 ; 51 (9). 2734-2741
39. Banach M, Hering D, Narkiewicz K, Mysliwiec M, Rysz J, Malyszko J.. Lipids, blood pressure, kidney-what was new in 2012?. Int J Pharmacol. 2012 ; 8 (8). 659-678
40. Katsiki N, Mikhailidis DP, Gotzamani-Psarrakou A, Didangelos TP, Yovos JG, Karamitsos DT. Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study. Open Cardiovasc Med J. 2011 ; 5: 136-147
41. Barylski M, Małyszko J, Rysz J, MyÅliwiec M, Banach M. Lipids, blood pressure, kidney - what was new in 2011?. Arch Med Sci. 2011 ; 7 (6). 1055-1066